AGF Investments LLC’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,311
Closed -$794K 437
2021
Q4
$794K Buy
3,311
+2,512
+314% +$646K 0.07% 177
2021
Q3
$226K Sell
799
-79
-9% -$25.9K 0.02% 283
2021
Q2
$304K Buy
+878
New +$266K 0.03% 274
2021
Q1
Sell
-1,828
Closed -$448K 431
2020
Q4
$448K Sell
1,828
-69
-4% -$17.8K 0.05% 252
2020
Q3
$538K Sell
1,897
-3,652
-66% -$1.02M 0.06% 236
2020
Q2
$1.49M Buy
5,549
+2,163
+64% +$650K 0.15% 90
2020
Q1
$1.07M Sell
3,386
-3,433
-50% -$1.04M 0.14% 90
2019
Q4
$2.02M Sell
6,819
-2,115
-24% -$587K 0.38% 67
2019
Q3
$2.08M Sell
8,934
-2,253
-20% -$525K 0.49% 57
2019
Q2
$2.62M Buy
11,187
+329
+3% +$76K 0.55% 55
2019
Q1
$2.57M Buy
10,858
+2,200
+25% +$693K 0.58% 56
2018
Q4
$2.6M Sell
8,658
-64
-0.7% -$20.4K 0.36% 66
2018
Q3
$3.08M Sell
8,722
-982
-10% -$338K 0.39% 65
2018
Q2
$2.82M Buy
9,704
+5,316
+121% +$1.49M 0.32% 76
2018
Q1
$1.2M Buy
+4,388
New +$1.36M 0.2% 100

Other funds holding BIIB

AGF Investments LLC's BIIB Position: Q1 2022 in Review

AGF Investments LLC sold out of Biogen (BIIB) in Q1 2022, closing a stake of 3,311 shares — an estimated $794K sold.

AGF Investments LLC first reported a position in BIIB in Q1 2018 and held it in 15 quarters. The position peaked at $3.08M in Q3 2018. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • AGF Investments LLC reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • AGF Investments LLC sold 3,311 Biogen shares in Q1 2022, an estimated $794K.
  • AGF Investments LLC first reported a position in Biogen in Q1 2018 and held it in 15 quarters.
  • AGF Investments LLC's Biogen position peaked at $3.08M in Q3 2018.
  • 951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on AGF Investments LLC's 13F filing for Q1 2022, filed 10 May 2022.